Clicking a link below will scroll the
page down to the relevant section
- A Phase I Study of Post-Operative Radiation Therapy plus RAD001 (Everolimus) and Cisplatin for Patients with Head and Neck Cancer
Fury, Matthew, MD, PhD
[Protocol 08-138]
- A Phase I Study of RAD001 (Everolimus), Docetaxel, and Cisplatin as Induction Chemotherapy for Patients with Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Fury, Matthew, MD, PhD
[Protocol 09-028]
- A Phase II Study Comparing Two Different Doses of Biweekly Cetuximab for Platinum-Refractory Cancers of the Head and Neck
Fury, Matthew, MD, PhD
[Protocol 08-039]
- A Phase II Trial of Bevacizumab, Cetuximab, Cisplatin, and Intensity-Modulated Radiation Therapy for Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma
Fury, Matthew, MD, PhD
[Protocol 09-083]
- A Phase II Trial of Chemoradiotherapy Alone or with Vandetanib for High-Risk Advanced Squamous Cell Carcinoma of the Head and Neck
Lee, Nancy, MD
[Protocol 09-103]
- Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction
Pusic, Andrea, MD, MHS
[Protocol 07-098]
- Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients
Lee, Nancy, MD
[Protocol 04-070]
- Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging to Assess Tongue Function after Treatment for Tongue Cancer
Kraus, Dennis, MD
[Protocol 02-093]
- Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging
Kraus, Dennis, MD
[Protocol 05-036]
- Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief
Pusic, Andrea, MD, MHS
[Protocol 07-150]
- Phase I Study of Weekly Nanoparticle Albumin-Bound Paclitaxel with Cetuximab and Intensity-Modulated Radiation Therapy in Patients with Locally Advanced Head and Neck Cancer
Fury, Matthew, MD, PhD
[Protocol 08-084]
- Phase II Study of Docetaxel Plus Cetuximab and Concurrent Re-Irradiation (Intensity-Modulated Radiation Therapy) for Patients with Locoregionally Recurrent Head and Neck Cancer
Fury, Matthew, MD, PhD
[Protocol 08-050]
- Pilot Study of Sulindac, a Pan-COX Inhibitor, in Oral Premalignant Lesions
Boyle, Jay, MD
[Protocol 04-099]
|
